Search

Maharashtra FDA ordered to file a FIR against Snapdeal and its CEO Kunal Behl

The FDA found that 45 of the displayed drugs were with objectionable claims which contravened the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

May 2, 2015 15:13 IST
facebook IconTwitter IconWhatsapp Icon

Maharashtra Food and Drug Administration (FDA) on 1 May 2015 ordered to file a FIR against the Snapdeal, its CEO Kunal Bahl and Directors for allegedly selling prescription drugs online. Selling of drugs without prescription is a crime under the Drugs and Cosmetics Act, 1940.

The FIR was filed after FDA officer on an investigation found that Jasper Infotech Pvt. Ltd. entered into agreements with dealers across India to supply medicines offered or exhibited for sale on its website, snapdeal.com, and to collect the sale proceeds on their behalf.

The FDA found that 45 of the displayed drugs were with objectionable claims which contravened the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

The FDA will be investigating other online shopping companies such as Flipkart and Amazon.

Now get latest Current Affairs on mobile, Download # 1  Current Affairs App

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐप

AndroidIOS